The Georgia Clinical and Translational Science Alliance (GaCTSA) is a compelling partnership of Emory University, Morehouse School of Medicine, the Georgia Institute of Technology and the University of Georgia, a new academic member adding resources and assets to our CTSA. Also key to GaCTSA are our healthcare partners: Emory Healthcare, Morehouse Healthcare, Children?s Healthcare of Atlanta, the Atlanta VA Medical Center, the Grady Health System, and the Atlanta Community Physicians Network and our translational science partners including the Yerkes National Primate Research Center (located at Emory), the Georgia Research Alliance, Georgia Bio and links to the Prevention Research Centers of the US Centers for Disease Control and Prevention (CDC). Built over the past decade of collaboration, the partners of GaCTSA have forged strong research networks and GaCTSA has become a ?24 hour? home and catalyst for innovative, high quality clinical and translational research with local, national and global impact. The addition of UGA allows the GaCTSA to better engage the large, rural and underserved populations of our state and adds new resources, including: outstanding translational research in glycobiology, infectious diseases, One Health, a new clinical and translational research unit, outstanding programs in Education, a School of Pharmacy; a robust extension service that reaches beyond its original agricultural mission to focus on family health; and the Archway Partnership whose mission is to connect Georgia communities with higher education resources to address critical, locally identified community needs. In addition to facilitating innovative science, GaCTSA will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research and accelerate the process of translating biomedical discoveries into clinical applications. Key to the next funding cycle, GaCTSA will emphasize innovative training and workforce development, access to and integration of special and underserved populations, enhanced biomedical informatics support and capabilities, new methods and processes to improve quality and efficiency, enhanced collaboration and engagement and team-based, quality focused predictive science.
The specific aims of GaCTSA reflect the vision and goals of NCATS Advisory Council Working Group and the recommendations of the 2013 IOM review of the CTSA program. The GaCTSA?s specific aims will serve as guiding principles to drive the vision and approach.

Public Health Relevance

Created in response to the NIH CTSA program, the Georgia Clinical & Translational Science Alliance (GaCTSA) serves as a catalyst and incubator for clinical and translational research across Georgia and with regional and national impact. In addition to facilitating innovative science, we will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research, and accelerate the process of translating biomedical discoveries into clinical applications.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1TR002378-01
Application #
9514466
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Davis Nagel, Joan
Project Start
2017-09-22
Project End
2022-06-30
Budget Start
2017-09-22
Budget End
2018-06-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Fitzpatrick, Anne M; Bacharier, Leonard B; Guilbert, Theresa W et al. (2018) Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future Exacerbation. J Allergy Clin Immunol Pract :
Collins, Jeffrey M; Hunter, Mary; Gordon, Wanda et al. (2018) False-Positive Tuberculin Skin Test Results Among Low-Risk Healthcare Workers Following Implementation of Fifty-Dose Vials of Purified Protein Derivative. Infect Control Hosp Epidemiol 39:750-752
Hall, Meldra; Engler, Jeffrey; Hemming, Japera et al. (2018) Using a Virtual Community (the Health Equity Learning Collaboratory) to Support Early-Stage Investigators Pursuing Grant Funding. Int J Environ Res Public Health 15:
Gomez-Peralta, Fernando; Abreu, Cristina; Gomez-Rodriguez, Sara et al. (2018) Safety and Efficacy of DPP4 Inhibitor and Basal Insulin in Type 2 Diabetes: An Updated Review and Challenging Clinical Scenarios. Diabetes Ther 9:1775-1789
Samman Tahhan, Ayman; Hammadah, Muhammad; Raad, Mohamad et al. (2018) Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes. Circ Res 122:1565-1575
Baliashvili, D; Kempker, R R; Blumberg, H M et al. (2018) A population-based tuberculosis contact investigation in the country of Georgia. Public Health Action 8:110-117
Okwan-Duodu, Derick; Hansen, Laura; Joseph, Giji et al. (2018) Impaired Collateral Vessel Formation in Sickle Cell Disease. Arterioscler Thromb Vasc Biol 38:1125-1133
Davis, Georgia; Fayfman, Maya; Reyes-Umpierrez, David et al. (2018) Stress hyperglycemia in general surgery: Why should we care? J Diabetes Complications 32:305-309
Kanhere, Mansi; He, Jiabei; Chassaing, Benoit et al. (2018) Bolus Weekly Vitamin D3 Supplementation Impacts Gut and Airway Microbiota in Adults With Cystic Fibrosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. J Clin Endocrinol Metab 103:564-574
Salindri, Argita D; Sales, Rose-Marie F; DiMiceli, Lauren et al. (2018) Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014. Ann Am Thorac Soc 15:331-340

Showing the most recent 10 out of 87 publications